

Cover Story
Conversation with The Cancer LetterFree
In recent years, NCI spending on extramural research has been following the same trajectory as Congressional appropriations for the institute: up, up, up.
Free
By Claire Dietz and Matthew Bin Han Ong
In Brief
Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- George Sigounas named the first-ever chief science advisor at NCI
- Makary: Level of evidence is an artificial and dogmatic construct
- The other side of the patient portal: Reflections from a cancer center leader
- Surviving cancer is often not a patient’s most challenging battle